Doctor Jaya Chandrasekhar
Eastern Health, Melbourne (Australia)
Associations between metabolic syndrome at index PCI and 1-year outcomes
Event: ESC Congress 2021 - The Digital Experience
Topic: Revascularisation
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
Associations between the PARIS ischaemic and bleeding risk scores and 1-year mortality in an all-comers Australian national PCI cohort
Event: ESC Congress 2021 - The Digital Experience
Topic: Revascularisation
Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters
COMBO PCI outcomes in patients categorized by baseline PARIS bleeding risk score: from the global MASCOT registry
Event: ESC Congress 2018
Topic: Stents
Session: Coronary interventions - Stents
COMBO stent PCI for elderly patients: one year clinical outcomes and DAPT cessation patterns from the global MASCOT registry
Event: ESC Congress 2018
Topic: Stents
Session: Coronary interventions: stents
Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration
Event: ESC Congress 2018
Topic: Stents
Session: Coronary interventions: stents
Evaluation of thienopyridine prescription in real world PCI by DAPT and ACUITY clinical risk scores: results from the PROMETHEUS study
Event: ESC Congress 2016
Topic: Thrombosis and platelets
Session: Antiplatelet therapy
Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention
Event: ESC Congress 2016
Topic: Thrombosis and platelets
Session: Antiplatelet therapy
The impact of DAPT clinical risk score and ACUITY bleeding risk score in determining adverse clinical outcomes following PCI: results from the PROMETHEUS study
Event: ESC Congress 2016
Topic: PCI: long-term outcome
Session: Factors influencing long term PCI outcomes
ESC 365 is supported by
